However, the ILC1 transitional signature used, including cytotoxicity genes PRF1, GZMB, and GNLY, is associated to ieILC1s rather than CD127+ ILC1 [47], [53], leaving the possibility that in CRC ILC3s may convert into ieILC1s. The gene discussed is IL7R; the disease is colorectal carcinoma.